Submitted by Anonymous (not verified) on 7 January 2026 - 8:09
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Trazimera, trastuzumab, Date of authorisation: 26/07/2018, Revision: 15, Status: Authorised